Technical Analysis for BIO - Bio-Rad Laboratories, Inc.
|Grade||Last Price||% Change||Price Change|
BIO closed up 0.07 percent on Tuesday, December 12, 2017, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
|Weak or Absent||Up||Up||Down|
|See historical BIO trend table...|
|Date||Alert Name||Type||% Chg|
|Dec 12||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.00%|
|Dec 12||Narrow Range Bar||Range Contraction||0.00%|
|Dec 12||NR7||Range Contraction||0.00%|
|Dec 12||Inside Day||Range Contraction||0.00%|
|Dec 12||Wide Bands||Range Expansion||0.00%|
|Dec 12||Oversold Stochastic||Weakness||0.00%|
|Dec 11||Stochastic Buy Signal||Bullish||0.07%|
|Dec 11||Non-ADX 1,2,3,4 Bullish||Bullish Swing Setup||0.07%|
|Dec 11||Wide Bands||Range Expansion||0.07%|
|Dec 11||Oversold Stochastic||Weakness||0.07%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Bio-Rad Laboratories, Inc. manufactures and supplies products and systems used to separate complex chemical and biological materials, and to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force and a service network worldwide. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more BIO news...
|52 Week High||273.87|
|52 Week Low||177.68|
|200-Day Moving Average||223.9408|
|50-Day Moving Average||241.9306|
|20-Day Moving Average||258.244|
|10-Day Moving Average||259.118|
|Average True Range||5.9045|
|Chandelier Exit (Long, 3 ATRs )||256.1565|
|Chandelier Exit (Short, 3 ATRs )||268.7135|
|Upper Bollinger Band||269.4059|
|Lower Bollinger Band||247.0821|
|Percent B (%b)||0.28|
|MACD Signal Line||5.3052|
|Market Cap||7.51 Billion|
|Num Shares||29.6 Million|
|Price-to-Earnings (P/E) Ratio||496.76|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||257.10|
|Resistance 3 (R3)||256.85||255.36||256.48|
|Resistance 2 (R2)||255.36||254.40||255.48||256.27|
|Resistance 1 (R1)||254.35||253.81||254.86||254.60||256.06|
|Support 1 (S1)||251.85||251.90||252.36||252.10||250.64|
|Support 2 (S2)||250.36||251.31||250.48||250.43|
|Support 3 (S3)||249.35||250.36||250.23|
|Support 4 (S4)||249.60|